TY - JOUR
T1 - HMGA1 Co-activates Transcription in B Cells through Indirect Association with DNA
AU - McCarthy, Kevin M.
AU - McDevit, Daniel
AU - Andreucci, Amy
AU - Reeves, Raymond
AU - Nikolajczyk, Barbara S.
PY - 2003/10/24
Y1 - 2003/10/24
N2 - The immunoglobulin heavy chain enhancer, or μ enhancer, is required for B cell development. Only the appropriate combination of transcription factors results in B cell-specific enhancer activation. HMGA1 (formerly (HMG-I(Y)) is a proposed co-activator of the ETS transcription factors required for μ enhancer activity. HMGA1 associates with the ETS factor PU.1, resulting in changes in PU.1 structure, and enhanced transcriptional synergy with Ets-1 on the μ enhancer in non-lymphoid cells. New data show HMGA1 directly interacts with Ets-1 in addition to PU.1. In vitro HMGA1/Ets-1 interaction facilitates Ets-1/μ enhancer binding in the absence of an HMGA1·Ets-1·DNA complex. To address whether HMGA1 is present in the transcriptionally active μ nucleoprotein complex, we completed DNA pull-down assays to detect protein tethering in the context of protein/DNA interaction. Results show that HMGA1 is not tightly associated with μ enhancer DNA through PU.1 or Ets-1, despite strong associations between these proteins in solution. However, chromatin immunoprecipitation assays show HMGA1 associates with the endogenous enhancer in B cells. Furthermore, antisense HMGA1 substantially decreases μ enhancer activity in B cells. Taken together, these data suggest that HMGA1 functions as a transcriptional μ enhancer co-activator in B cells through indirect association with DNA.
AB - The immunoglobulin heavy chain enhancer, or μ enhancer, is required for B cell development. Only the appropriate combination of transcription factors results in B cell-specific enhancer activation. HMGA1 (formerly (HMG-I(Y)) is a proposed co-activator of the ETS transcription factors required for μ enhancer activity. HMGA1 associates with the ETS factor PU.1, resulting in changes in PU.1 structure, and enhanced transcriptional synergy with Ets-1 on the μ enhancer in non-lymphoid cells. New data show HMGA1 directly interacts with Ets-1 in addition to PU.1. In vitro HMGA1/Ets-1 interaction facilitates Ets-1/μ enhancer binding in the absence of an HMGA1·Ets-1·DNA complex. To address whether HMGA1 is present in the transcriptionally active μ nucleoprotein complex, we completed DNA pull-down assays to detect protein tethering in the context of protein/DNA interaction. Results show that HMGA1 is not tightly associated with μ enhancer DNA through PU.1 or Ets-1, despite strong associations between these proteins in solution. However, chromatin immunoprecipitation assays show HMGA1 associates with the endogenous enhancer in B cells. Furthermore, antisense HMGA1 substantially decreases μ enhancer activity in B cells. Taken together, these data suggest that HMGA1 functions as a transcriptional μ enhancer co-activator in B cells through indirect association with DNA.
UR - http://www.scopus.com/inward/record.url?scp=0142211260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142211260&partnerID=8YFLogxK
U2 - 10.1074/jbc.M308586200
DO - 10.1074/jbc.M308586200
M3 - Article
C2 - 12907668
AN - SCOPUS:0142211260
SN - 0021-9258
VL - 278
SP - 42106
EP - 42114
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 43
ER -